Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX – Get Free Report)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $17.85, but opened at $17.41. Telix Pharmaceuticals Limited American Depositary Shares shares last traded at $17.00, with a volume of 61,506 shares traded.
Wall Street Analysts Forecast Growth
TLX has been the topic of a number of recent analyst reports. William Blair raised shares of Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research report on Tuesday, November 19th. UBS Group lifted their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the stock a “buy” rating in a report on Monday, January 27th.
Read Our Latest Stock Analysis on Telix Pharmaceuticals Limited American Depositary Shares
Telix Pharmaceuticals Limited American Depositary Shares Price Performance
Telix Pharmaceuticals Limited American Depositary Shares Company Profile
Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.
Further Reading
- Five stocks we like better than Telix Pharmaceuticals Limited American Depositary Shares
- 5 Top Rated Dividend Stocks to Consider
- Oracle Stock: 5 Reasons This AI Powerhouse Is a Long-Term Buy
- Industrial Products Stocks Investing
- U.S. Stocks Sink, Foreign Markets Soar: 3 ETFs to Ride the Wave
- What is diluted earnings per share (Diluted EPS)?
- Joby Aviation: From Prototype to Profitability
Receive News & Ratings for Telix Pharmaceuticals Limited American Depositary Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Telix Pharmaceuticals Limited American Depositary Shares and related companies with MarketBeat.com's FREE daily email newsletter.
